XML 37 R24.htm IDEA: XBRL DOCUMENT
v3.3.0.814

Investment In Inex Bio, Inc (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2015
Summary of Purchase Price Paid to Inex Bio | The following summarizes the net consideration paid to Holdings:
Consideration |  | Total |
Cash |  | $ | 6,518 |
Fair value of warrants |  |  | 22,747 |
Less cash paid to acquire shares in Inex Bio |  |  | (1,100 | )
Net consideration |  | $ | 28,165 |
Summary of Assets and Liabilities Assumed | The following table summarizes the assets acquired and liabilities assumed:
Cash |  | $ | 763 |
Intangible assets—reacquired rights of Company technology |  |  | 7,199 |
Other assets |  |  | 12 |
Investment in Inex Bio |  |  | (221 | )
Accounts payable |  |  | (1 | )
Total assets acquired and liabilities assumed |  | $ | 7,752 |
Inex Bio Inc |
Summary of Purchase Price Paid to Inex Bio | The purchase price paid to acquire Inex Bio from the other owners is as follows:
Consideration |  | Total |
Cash paid by InexBio Holdings, LLC |  | $ | 1,100 |
Cash paid by Company |  |  | 1,482 |
Fair value of warrants |  |  | 5,170 |
Aggregate purchase price |  | $ | 7,752 |

X
- Definition Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=nk_InexBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |